🇺🇸 FDA
Patent

US 9119884

LLP2A-bisphosphonate conjugates for osteoporosis treatment

granted A61KA61K31/00A61K31/66

Quick answer

US patent 9119884 (LLP2A-bisphosphonate conjugates for osteoporosis treatment) held by The Regents of the University of California expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/00, A61K31/66, A61K31/661, A61K31/663